Physician profile
Anthony D Boxrud
NPI 1316597123
$1,824.44
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $390 · 2023: $708 · 2024: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $714.48 | 2021-2024 | |
| Lilly USA, LLC | $207.42 | 2021-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $141.42 | 2023-2024 | Farxiga, Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $138.95 | 2021-2024 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.87 | 2022-2023 | Jardiance |
| Pfizer INC. | $75.63 | 2023-2024 | |
| Abbott Laboratories | $73.56 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Daiichi Sankyo INC. | $72.70 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.92 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.11 | 2022 | |
| Arbor Pharmaceuticals, INC. | $27.39 | 2021 | |
| Jazz Pharmaceuticals INC. | $24.45 | 2022 | |
| Gilead Sciences, INC. | $17.94 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $17.53 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.27 | 2023 | Quviviq |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.24 | 2024 | Veozah |
| Amarin Pharma, INC. | $16.41 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.89 | 2021 | |
| Amgen INC. | $15.87 | 2023 | Repatha, Otezla |
| Novo Nordisk INC | $13.68 | 2021 | |
| Genentech USA, INC. | $5.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Boxrud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.